Clinical trial
A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in…
NCT00235443 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00235443 |
|---|---|
| Title | A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy |
| Official title | A Multi-Center, Open-Label, Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy |
| Intervention type | Drug |
| Interventions | lacosamide |
| Enrollment | 451 |
| Start date | Sep 1, 2004 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Oct 10, 2005 |
| Last update posted | Jul 17, 2018 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: